| | Business Summary | | Carter-Wallace,
Inc.
manufactures
and
sells
a
diversified
line
of
healthcare
products,
including
pharmaceuticals,
toiletries
and
pet
products.
In
May
2001,
the
Company
announced
that
it
had
entered
into
agreements
to
sell
the
Company.
In
this
two-step
transaction,
the
Company
will
sell
the
consumer
business,
consisting
of
the
Carter,
Lambert
Kay
and
International
Divisions
immediately
prior
to
the
merger
of
the
remainder
of
the
Company. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Carter-Wallace
manufactures
and
sells
a
line
of
consumer
health
care
products
such
as
deodorants,
toothpaste,
cough
and
cold
products,
pet
supplies
etc.
For
the
three
months
ended
6/30/01,
revenues
rose
5%
to
$238.6
million.
Net
income
rose
28%
to
$28.6
million.
Revenues
reflect
higher
unit
volume
and
increased
selling
prices.
Net
income
also
reflects
decreased
cost
of
goods
sold
as
a
percentage
of
revenues
due
to
a
change
in
product
mix. | | More
from
Market Guide: Significant
Developments |
| | | | FY2001 Pay | |
| Ralph Levine, 65
Chairman,
CEO | $2.5M | Paul Veteri, 59
Pres,
COO, Director | 1.9M | Peter Griffin, 58
CFO,
VP-Fin., Controller | -- | James Wagar, 66
VP
and Treasurer | -- | Stephen Lang, 66
VP,
Sec. and Gen. Counsel | 860K | | Dollar amounts are as of 31-Mar-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/c/car.gif)